Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for NATR and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for NATR and 80,000+ other tickers.
See exactly how NATR's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for NATR and 80,000+ other tickers.
Nature's Sunshine Products, Inc. is a natural health and wellness enterprise that primarily manufactures and distributes a wide array of nutritional supplements and personal care products. The company's operational reach spans several continents, including Asia, Europe, North America, and Latin America. Its comprehensive nutritional offerings cater to general well-being, providing support for blood sugar regulation, bone density, cellular vitality, cognitive sharpness, joint mobility, mood balance, sexual wellness, sleep quality, athletic performance, and visual acuity. Additionally, it…
Nature's Sunshine Products (NASDAQ: NATR - Get Free Report) and Natural Health Trends (NASDAQ: NHTC - Get Free Report) are both small-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Insider and Institutional Ownership
Nature's Sunshine Products (NASDAQ: NATR) outlined a strategy to double sales to $1 billion and expand EBITDA margins to 15%, with Chief Executive Officer Ken Romanzi pointing to geographic expansion, digital and retail channel development, marketing initiatives and acquisitions as the company's primary growth drivers. Speaking at a Canaccord consumer conference, Romanzi said the natural health
Nature's Sunshine Products NASDAQ: NATR outlined a strategy to double sales to $1 billion and expand EBITDA margins to 15%, with Chief Executive Officer Ken Romanzi pointing to geographic expansion, digital and retail channel development, marketing initiatives and acquisitions as the company's primary growth drivers.
Nature's Sunshine Products, Inc. (NASDAQ: NATR - Get Free Report) major shareholder Prescott Group Capital Managem bought 96,000 shares of the company's stock in a transaction that occurred on Friday, August 7th. The stock was purchased at an average cost of $16.63 per share, with a total value of $1,596,480.00. Following the acquisition, the insider directly
Nature's Sunshine Products, Inc. (NATR) Q2 2026 Earnings Call Transcript